Skip to content
  • Brazil
  • Canada
  • Europe
  • India
  • Italy
  • Japan
  • Korea
  • Latam
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
  • Country/Region
  • No block ID is set

  • Clinic Portal
    • +0034963905310
  • Request Information
  • +34 96 390 53 10
  • Part of brands: |
InternationalInternational
  • Country/Region
  • Part of brands: |
  • Patient Journey
    • Before Pregnancy
    • IVF Process
    • Healthy pregnancy
    • After birth
  • Reproductive Health
    • Specialists
      • ERA
      • ERA insight Hub
      • ALICE
      • EMMA
      • EndomeTRIO
      • Infertility Panels
      • EMBRACE
      • PGT-A
      • PGT-A Plus
      • PGT-M
      • PGT-SR
      • CGT
      • NACE
      • Zenit
      • POC Portfolio
      • SAT
      • Newborn Screening
  • Diagnostics
  • About us
    • Igenomix Research
    • About Igenomix
    • Igenomix Worldwide
  • Academy
  • Blog
Genomics Precision Diagnostic > Connective Tissue Disorder > Marfan Syndrome Precision Panel

Marfan Syndrome Precision Panel

Marfan Syndrome (MFS) is a spectrum of disorders caused by a genetic defect of the connective tissue and it is inherited in an autosomal dominant pattern. Since the connective tissue is the tissue that helps body growth as well as serving as a scaffold for cells and organs, Marfan Syndrome is a pleiotropic syndrome affecting mainly musculoskeletal, cardiac and ocular systems. 
Overview
Indication
Clinical Utility
Genes & Diseases
Methodology
References

Overview

  • Marfan Syndrome (MFS) is a spectrum of disorders caused by a genetic defect of the connective tissue and it is inherited in an autosomal dominant pattern. Since the connective tissue is the tissue that helps body growth as well as serving as a scaffold for cells and organs, Marfan Syndrome is a pleiotropic syndrome affecting mainly musculoskeletal, cardiac and ocular systems. The most severe of these manifestations include aortic root dilation and dissection, which are responsible for early patient demise. Pregnancy is a time of increased cardiovascular risk for women with Marfan syndrome, so an early diagnosis is key in pregnancy management. 

  • The Igenomix Marfan Syndrome Precision Panel can be used to make an accurate and directed diagnosis as well as a differential diagnosis of connective tissue disorders due to their overlapping phenotypic features ultimately leading to a better management and prognosis of the disease. It provides a comprehensive analysis of the genes involved in this disease using next-generation sequencing (NGS) to fully understand the spectrum of relevant genes involved.

Indication

  • The Igenomix Marfan Syndrome Precision Panel is indicated for those patients with a clinical suspicion or diagnosis with or without the following manifestations: 
    • Subluxation of lenses 
    • Cardiovascular findings: mitral valve prolapse, aortic regurgitation, mitral regurgitation, aortic dilation, dissection or aneurysm 
    • Tall and thin stature 
    • Long fingers and toes  
    • Pectus carinatum or excavatum 
    • Scoliosis 
    • Hypermobile joints 
    • Severe hindfoot valgus 

Clinical Utility

The clinical utility of this panel is: 

  • The genetic and molecular confirmation for an accurate clinical diagnosis of a symptomatic patient. Understanding global and molecular functions of fibrillin containing microfibrils for the development of a comprehensive theory of pathogenesis.   
  • Early initiation of treatment with a multidisciplinary team in the form of medical treatment and surveillance to prevent vascular complications and/or surgical care in case of development of vascular compromise. 
  • Risk assessment and genetic counselling of asymptomatic family members according to the mode of inheritance. 
  • Improvement of delineation of genotype-phenotype correlation due to overlapping features of connective tissue disorders. 

Genes & Diseases

Methodology

References

See scientific referrals

Ammash, N., Sundt, T., & Connolly, H. (2008). Marfan Syndrome—Diagnosis and Management. Current Problems In Cardiology, 33(1), 7-39. doi: 10.1016/j.cpcardiol.2007.10.001 

Dietz, H., Cutting, C., Pyeritz, R., Maslen, C., Sakai, L., & Corson, G. et al. (1991). Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature, 352(6333), 337-339. doi: 10.1038/352337a0 

Yuan, S. M., & Jing, H. (2010). Marfan’s syndrome: an overview. Sao Paulo medical journal = Revista paulista de medicina, 128(6), 360–366. https://doi.org/10.1590/s1516-31802010000600009 

Dean J. C. (2007). Marfan syndrome: clinical diagnosis and management. European journal of human genetics : EJHG, 15(7), 724–733. https://doi.org/10.1038/sj.ejhg.5201851 

Pyeritz R. E. (2019). Marfan syndrome: improved clinical history results in expanded natural history. Genetics in medicine : official journal of the American College of Medical Genetics, 21(8), 1683–1690. https://doi.org/10.1038/s41436-018-0399-4 

Robinson, P. N., & Godfrey, M. (2000). The molecular genetics of Marfan syndrome and related microfibrillopathies. Journal of medical genetics, 37(1), 9–25. https://doi.org/10.1136/jmg.37.1.9 

von Kodolitsch, Y., & Robinson, P. N. (2007). Marfan syndrome: an update of genetics, medical and surgical management. Heart (British Cardiac Society), 93(6), 755–760. https://doi.org/10.1136/hrt.2006.098798 

descargar

Detail description

Download

Request Information

WE GUIDE YOU

Fertility
Inherited diseases prevention
Healthy pregnancy

To see the accreditation certificate, associated technical annex and list of accredited tests, click on this link.

OUR SERVICES

Genetic testing solutions
For patients
How to send a sample?
User manual

ABOUT US

About Igenomix
Contact
Quality
Complaints
Work with us
Terms and conditions

FOLLOW IGENOMIX

  + 96 390 53 10
  Write us
  • Brazil
  • Canada
  • Europe
  • India
  • Italy
  • Japan
  • Korea
  • Latam
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
Country/Region

[2024] © Igenomix Privacy Page Quality policy Legal note Cookies policy

Request Information


  • Patient Journey
    • Before Pregnancy
    • IVF Process
    • Healthy pregnancy
    • After birth
  • Reproductive Health
    • Specialists
      • ERA
      • ERA insight Hub
      • ALICE
      • EMMA
      • EndomeTRIO
      • Infertility Panels
      • EMBRACE
      • PGT-A
      • PGT-A Plus
      • PGT-M
      • PGT-SR
      • CGT
      • NACE
      • Zenit
      • POC Portfolio
      • SAT
      • Newborn Screening
  • Diagnostics
  • About us
    • Igenomix Research
    • About Igenomix
    • Igenomix Worldwide
  • Academy
  • Blog
  • Country/Region
  • +34 96 390 53 10
  • Clinic Portal
  • Request Information